INTRODUCTION AND OBJECTIVES: Men and women are equally likely to carry mutations in hereditary cancer genes and both have elevated cancer risks. Prostate cancer (PC) has been associated with germline mutations in several genes, especially BRCA2; which has also been associated with more aggressive disease with significantly lower cause-specific survival. The National Comprehensive Cancer Network (NCCN) guidelines for hereditary breast and ovarian cancer (HBOC) recommend genetic testing for men with a personal and/or family history of high Gleason score prostate cancer with family history of breast, ovarian, and/or pancreatic cancer. Despite this, over 95% of patients who have hereditary cancer multi-gene panel testing (MGPT) are women. We sought to describe results of MGPT in men with PC compared to women with breast cancer (BC).
INTRODUCTION AND OBJECTIVES: Despite a favorable sensitivity profile for high grade and large volume disease, indiscriminate use of multiparametric prostate MRI (mpMRI) adds prohibitory cost with uncertain benefit. Our study aims to identify clinical predictors of suspicious lesions on imaging to improve patient selection for mpMRI.
METHODS: We performed a retrospective review of 839 patients undergoing mpMRI for elevated PSA between March 2012 and October 2014. mpMRI was performed on 3T magnet with pelvic phased array and endorectal coils. Baseline clinical and biochemical patient characteristics were analyzed with univariable and multivariable logistic regression to identify predictors of a positive MRI (PIRADS score 3-5). Using these variables, we constructed a nomogram to predict a positive MRI.
RESULTS: Among 839 patients without prior history of prostate cancer, MRI was positive in 272 (32.4%) patients. Increasing age (P¼0.001), abnormal digital rectal exam (P¼0.002), prior negative biopsy (P<0.001), increasing pre-MRI PSA (P<0.001), lower prostate volume (P<0.001), and PSA velocity (P¼0.044) were significant predictors of a positive MRI in univariable analysis. On multivariable analysis, age (P¼0.048), positive digital rectal exam (P¼0.017), prior negative biopsy (P¼0.061), pre-MRI PSA (P<0.001), and prostate volume (P<0.001) remained independent predictors (Table) . A nomogram predicting probability of a positive mpMRI based on these variables demonstrated good calibration and a concordance index of 0.7 (Figure) .
CONCLUSIONS: Many of the clinical variables traditionally associated with increased PCa risk are also independently associated with a positive mpMRI. A nomogram including these variables can help identify men who are more likely to benefit from a prostate mpMRI while reducing cost by limiting the number of negative studies.
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